title: [Cancer of the thoracic esophagus. Therapeutic strategy].
abstract: Out of 100 patients with oesophageal carcinoma, 39 will have the tumour resected, 26 will survive the operation, and only 4 will be alive after 5 years. Although surgical resection is the best treatment for squamous cell carcinoma, new trends in pre-operative chemotherapy should provide better results. A therapeutic regimen based on data from the literature and on personal experience is suggested as neoadjuvant chemotherapy in operable and in nonsurgical tumours. Operability should be re-evaluated after 2 courses of chemotherapy according to response rate. Surgical possibilities and post-operative treatment depend on this response. Surgical procedures and the indications of surgery are described.
authors.affiliation: Centre Paul Lamarque, Montpellier.
authors.forename: J
authors.initials: J
authors.lastname: Domergue
authors.forename: P
authors.initials: P
authors.lastname: Rouanet
authors.forename: J B
authors.initials: JB
authors.lastname: Dubois
authors.forename: J F
authors.initials: JF
authors.lastname: Rossi
authors.forename: H
authors.initials: H
authors.lastname: Pujol
mesh_terms: D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D004947:Esophagus / Q000601:surgery; D006801:Humans; D011379:Prognosis; D013524:Surgical Flaps; D013908:Thoracotomy
vernacular_title: Cancer de l'oesophage thoracique. Stratégie thérapeutique.